RA International – “until very recently the impact was limited to potential supply chain disruptions… however”...
Earlier this week I reviewed on InnovaDerma (IDP) argues “excellent progress”… so why a further 8%+ share price fall?. That was to 72.5p. Yesterday afternoon saw “Directorate Change” and shareholdings announcements – and the shares are currently around 60p…
InnovaDerma (IDP) has updated including “strong performances across our topical brands and Prolong… Skinny Tan will benefit from a full-year's contribution from its ranging in 1,300 Boots' stores and continued innovation during this financial year. Boots has also increased shelving for Roots… For the first four months of the new financial year, revenues were 38% higher compared with the same period last year”. Having started 2019 rising above 90p, the shares are though currently a further more than 8% lower on the day at 72.5p. Hmmm…
Previously writing, in November, as shares in InnovaDerma (IDP) fell towards 100p, I concluded that there looked good reason for scepticism – with the company still needing to show delivery to suggest current year revenue and also, of course, bottom-line forecasts are achievable. Now a “Trading Statement” – and the shares down approaching 16%, below 80p, in response…
“UK developer of life sciences, beauty and personal care products”, InnovaDerma (IDP) has made an AGM update including “our distribution channels will increase significantly this financial year as our UK retail store network grows from c.800 (FY2017) to c.2,400”. So why a current 15% share price fall, towards 100p?...
I first warned on shares in InnovaDerma (IDP) in January as they fell towards 230p. Less than two months later it was a profit warning, though the shares are currently bouncing more than 25% higher today, towards 140p – a market cap of circa £20 million, on the back of an “Appointment of CEO and Roots to be ranged in Tesco” announcement…
Life sciences, beauty and personal care products company InnovaDerma (IDP) has updated on trading for its year ending 30th June – commencing “revenue for the period increased strongly by 23.5% on a constant currency basis to approximately £11m (FY2017: £8.9m). However,”, Uh oh…
Whenever a company doubles in share price in a short space of time it tends to get my attention, and I look for reasons that justify such a sudden increase.
Writing on InnovaDerma (IDP) in January with the shares towards 230p, I concluded at least ahead of further comfort of the second half weighting expected actually being delivered, I avoid. Now a 10:13 “Trading Statement”. Uh oh…
InnovaDerma (IDP) “is pleased to provide a trading update for the six months ended 31 December 2017” - and it includes “the board remains confident in meeting market expectations for the current financial year and has much greater revenue visibility for the second half than in prior years”. So why an approaching 13% share price fall on the back of it, towards 230p?...
Search ShareProphets |
Recent Comments |